Winslow Evans & Crocker’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,402
| Closed | -$4K | – | 1198 |
|
|
2019
Q4 | $4K | Hold |
1,402
| – | – | ﹤0.01% | 1066 |
|
|
2019
Q3 | $4K | Hold |
1,402
| – | – | ﹤0.01% | 1055 |
|
|
2019
Q2 | $4K | Sell |
1,402
-1,402
| -50% | -$700 | ﹤0.01% | 1055 |
|
|
2019
Q1 | $8K | Hold |
2,804
| – | – | ﹤0.01% | 909 |
|
|
2018
Q4 | $8K | Hold |
2,804
| – | – | ﹤0.01% | 852 |
|
|
2018
Q3 | $8K | Hold |
2,804
| – | – | ﹤0.01% | 876 |
|
|
2018
Q2 | $8K | Buy |
2,804
+1,402
| +100% | +$653 | ﹤0.01% | 879 |
|
|
2018
Q1 | $596 | Hold |
1,402
| – | – | ﹤0.01% | 1090 |
|
|
2017
Q4 | $534 | Hold |
1,402
| – | – | ﹤0.01% | 1097 |
|
|
2017
Q3 | $506 | Sell |
1,402
-14
| -1% | -$5 | ﹤0.01% | 1088 |
|
|
2017
Q2 | $538 | Hold |
1,416
| – | – | ﹤0.01% | 1233 |
|
|
2017
Q1 | $638 | Buy |
1,416
+40
| +3% | +$18 | ﹤0.01% | 1201 |
|
|
2016
Q4 | $524 | Hold |
1,376
| – | – | ﹤0.01% | 1212 |
|
|
2016
Q3 | $372 | Hold |
1,376
| – | – | ﹤0.01% | 1262 |
|
|
2016
Q2 | $332 | Hold |
1,376
| – | – | ﹤0.01% | 1252 |
|
|
2016
Q1 | $157 | Hold |
1,376
| – | – | ﹤0.01% | 1267 |
|
|
2015
Q4 | $158 | Hold |
1,376
| – | – | ﹤0.01% | 1349 |
|
|
2015
Q3 | $264 | Hold |
1,376
| – | – | ﹤0.01% | 1268 |
|
|
2015
Q2 | $964 | Hold |
1,376
| – | – | ﹤0.01% | 1242 |
|
|
2015
Q1 | $934 | Hold |
1,376
| – | – | ﹤0.01% | 1218 |
|
|
2014
Q4 | $1.09K | Hold |
1,376
| – | – | ﹤0.01% | 1229 |
|
|
2014
Q3 | $640 | Buy |
1,376
+850
| +162% | +$412 | ﹤0.01% | 1341 |
|
|
2014
Q2 | $263 | Hold |
526
| – | – | ﹤0.01% | 1273 |
|
|
2014
Q1 | $163 | Hold |
526
| – | – | ﹤0.01% | 1265 |
|
|
2013
Q4 | $0 | Buy |
+526
| New | +$636 | ﹤0.01% | 1427 |
|
Winslow Evans & Crocker's GCVRZ Position: Q1 2020 in Review
Winslow Evans & Crocker sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 1,402 shares — an estimated $4K sold.
Winslow Evans & Crocker first reported a position in GCVRZ in Q4 2013 and held it in 25 quarters. The position peaked at $8K in Q1 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Winslow Evans & Crocker reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Winslow Evans & Crocker sold 1,402 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $4K.
- Winslow Evans & Crocker first reported a position in Sanofi Contingent Value Rights in Q4 2013 and held it in 25 quarters.
- Winslow Evans & Crocker's Sanofi Contingent Value Rights position peaked at $8K in Q1 2019.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Winslow Evans & Crocker's 13F filing for Q1 2020, filed 20 Apr 2020.